541 related articles for article (PubMed ID: 19705621)
21. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety.
Van de Kerkhof PC; Werfel T; Haustein UF; Luger T; Czarnetzki BM; Niemann R; Plänitz-Stenzel V
Br J Dermatol; 1996 Nov; 135(5):758-65. PubMed ID: 8977677
[TBL] [Abstract][Full Text] [Related]
22. Clinical effect of vitamin D3 analogues is not inactivated by subsequent UV exposure.
Adachi Y; Uchida N; Matsuo T; Horio T
Photodermatol Photoimmunol Photomed; 2008 Feb; 24(1):16-8. PubMed ID: 18201352
[TBL] [Abstract][Full Text] [Related]
23. Does the determination of the Bb vitamin D receptor genotype identify psoriasis vulgaris patients responsive to topical tacalcitol?
Giomi B; Ruggiero M; Fabbri P; Gulisano M; Peruzzi B; Caproni M; Pacini S
J Dermatol Sci; 2005 Mar; 37(3):180-1. PubMed ID: 15734288
[No Abstract] [Full Text] [Related]
24. Duration of remission period of narrowband ultraviolet B therapy on psoriasis vulgaris.
Karakawa M; Komine M; Takekoshi T; Sakurai N; Minatani Y; Tada Y; Saeki H; Tamaki K
J Dermatol; 2011 Jul; 38(7):655-60. PubMed ID: 21352300
[TBL] [Abstract][Full Text] [Related]
25. Effect of calcipotriol on etanercept partial responder psoriasis vulgaris and psoriatic arthritis patients.
Campione E; Mazzotta A; Paternò EJ; Diluvio L; Prinz JC; Chimenti S
Acta Derm Venereol; 2009; 89(3):288-91. PubMed ID: 19479128
[TBL] [Abstract][Full Text] [Related]
26. Phototherapy of psoriasis: comparative experience of different phototherapeutic approaches.
Karrer S; Eholzer C; Ackermann G; Landthaler M; Szeimies RM
Dermatology; 2001; 202(2):108-15. PubMed ID: 11306830
[TBL] [Abstract][Full Text] [Related]
27. Four cases of sebopsoriasis or seborrheic dermatitis of the face and scalp successfully treated with 1a-24 (R)-dihydroxycholecalciferol (tacalcitol) cream.
Nakayama J
Eur J Dermatol; 2000; 10(7):528-32. PubMed ID: 11056423
[TBL] [Abstract][Full Text] [Related]
28. The efficacy of 308nm laser treatment of psoriasis compared to historical controls.
Rodewald EJ; Housman TS; Mellen BG; Feldman SR
Dermatol Online J; 2001 Dec; 7(2):4. PubMed ID: 12165220
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of topical calcipotriol in psoriasis].
Welsh-Lozano O; Gómez-de Garza M; Jaramillo-Moreńo G; González-González SE; Morales-Monsiváis MA
Gac Med Mex; 1996; 132(5):471-4. PubMed ID: 9011512
[TBL] [Abstract][Full Text] [Related]
30. LCD plus NB-UVB reduces time to improvement of psoriasis vs. NB-UVB alone.
Bagel J
J Drugs Dermatol; 2009 Apr; 8(4):351-7. PubMed ID: 19363853
[TBL] [Abstract][Full Text] [Related]
31. Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo.
Lu-yan T; Wen-wen F; Lei-hong X; Yi J; Zhi-zhong Z
Photodermatol Photoimmunol Photomed; 2006 Dec; 22(6):310-4. PubMed ID: 17100739
[TBL] [Abstract][Full Text] [Related]
32. Calcipotriol/calcipotriene (Dovonex/Daivonex) in combination with phototherapy: a review.
Koo J
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S59-61. PubMed ID: 9344187
[TBL] [Abstract][Full Text] [Related]
33. Serum 5-S-cysteinyldopa levels in patients with psoriasis undergoing narrowband ultraviolet B phototherapy.
Kikuchi K; Wakamatsu K; Tada Y; Komine M; Ito S; Tamaki K
Clin Exp Dermatol; 2008 Nov; 33(6):750-3. PubMed ID: 18954414
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the efficacy of local narrowband ultraviolet B (NB-UVB) phototherapy versus psoralen plus ultraviolet A (PUVA) paint for palmoplantar psoriasis.
Sezer E; Erbil AH; Kurumlu Z; Taştan HB; Etikan I
J Dermatol; 2007 Jul; 34(7):435-40. PubMed ID: 17584319
[TBL] [Abstract][Full Text] [Related]
35. Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: a randomized, placebo-controlled study.
Asawanonda P; Nateetongrungsak Y
J Am Acad Dermatol; 2006 Jun; 54(6):1013-8. PubMed ID: 16713455
[TBL] [Abstract][Full Text] [Related]
36. Calcipotriol vs. tazarotene as combination therapy with narrowband ultraviolet B (311 nm): efficacy in patients with severe psoriasis.
Schiener R; Behrens-Williams SC; Pillekamp H; Kaskel P; Peter RU; Kerscher M
Br J Dermatol; 2000 Dec; 143(6):1275-8. PubMed ID: 11122033
[TBL] [Abstract][Full Text] [Related]
37. Quality of life in psoriasis improves after standardized administration of narrowband UVB phototherapy.
Lim C; Brown P
Australas J Dermatol; 2006 Feb; 47(1):37-40. PubMed ID: 16405481
[TBL] [Abstract][Full Text] [Related]
38. The effects of calcipotriol and methylprednisolone aseponate on bcl-2, p53 and ki-67 expression in psoriasis.
Adişen E; Gülekon A; Erdem O; Dursun A; Gürer MA
J Eur Acad Dermatol Venereol; 2006 May; 20(5):527-33. PubMed ID: 16684279
[TBL] [Abstract][Full Text] [Related]
39. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness and side effects of UVB-phototherapy, dithranol inpatient therapy and a care instruction programme of short contact dithranol in moderate to severe psoriasis.
Sminkels OQ; Prins M; Veeniiuis RT; De Boo T; Gerritsen MJ; Van Der Wilt GJ; Van De Kerkhof PC; Van Der Valk PG
Eur J Dermatol; 2004; 14(3):159-65. PubMed ID: 15246941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
